| Infiltration of tumour-associated macrophages in prostate biopsy specimens is predictive of disease progression after hormonal therapy for prostate cancer. N Nonomura, H Takayama, M Nakayama, Y Nakai, A Kawashima, ... BJU international 107 (12), 2011 | 226 | 2011 |
| Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer K Fujita, H Kume, K Matsuzaki, A Kawashima, T Ujike, A Nagahara, ... Scientific reports 7 (1), 42961, 2017 | 155 | 2017 |
| High-fat diet-induced inflammation accelerates prostate cancer growth via IL6 signaling T Hayashi, K Fujita, S Nojima, Y Hayashi, K Nakano, Y Ishizuya, C Wang, ... Clinical Cancer Research 24 (17), 4309-4318, 2018 | 132 | 2018 |
| ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori H Nagase, T Takeoka, S Urakawa, A Morimoto‐Okazawa, A Kawashima, ... International journal of cancer 140 (3), 686-695, 2017 | 114 | 2017 |
| High-dose-rate brachytherapy as monotherapy for intermediate-and high-risk prostate cancer: clinical results for a median 8-year follow-up Y Yoshioka, O Suzuki, F Isohashi, Y Seo, H Okubo, H Yamaguchi, M Oda, ... International Journal of Radiation Oncology* Biology* Physics 94 (4), 675-682, 2016 | 98 | 2016 |
| Gut microbiota–derived short-chain fatty acids promote prostate cancer growth via IGF1 signaling M Matsushita, K Fujita, T Hayashi, H Kayama, D Motooka, H Hase, ... Cancer research 81 (15), 4014-4026, 2021 | 97 | 2021 |
| CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory Y Kidani, W Nogami, Y Yasumizu, A Kawashima, A Tanaka, Y Sonoda, ... Proceedings of the National Academy of Sciences 119 (7), e2114282119, 2022 | 92 | 2022 |
| MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma K Matsuzaki, K Fujita, K Jingushi, A Kawashima, T Ujike, A Nagahara, ... Oncotarget 8 (15), 24668, 2017 | 88 | 2017 |
| Excision repair cross-complementing group 1 may predict the efficacy of chemoradiation therapy for muscle-invasive bladder cancer A Kawashima, M Nakayama, Y Kakuta, T Abe, K Hatano, M Mukai, ... Clinical Cancer Research 17 (8), 2561-2569, 2011 | 73 | 2011 |
| Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinoma Y Yamamoto, M Uemura, M Fujita, K Maejima, Y Koh, M Matsushita, ... Cancer science 110 (2), 617-628, 2019 | 72 | 2019 |
| Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell‐free DNA in upper tract urothelial carcinoma Y Hayashi, K Fujita, K Matsuzaki, M Matsushita, N Kawamura, Y Koh, ... Cancer science 110 (5), 1771-1779, 2019 | 68 | 2019 |
| Hyperbaric oxygen therapy for radiation‐induced hemorrhagic cystitis T Yoshida, A Kawashima, T Ujike, M Uemura, K Nishimura, S Miyoshi International journal of urology 15 (7), 639-641, 2008 | 65 | 2008 |
| EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome M Sato, Y Nakai, W Nakata, T Yoshida, K Hatano, A Kawashima, K Fujita, ... PloS one 8 (9), e74313, 2013 | 58 | 2013 |
| Expression of nectin-4 and PD-L1 in upper tract urothelial carcinoma E Tomiyama, K Fujita, MDC Rodriguez Pena, D Taheri, E Banno, T Kato, ... International journal of molecular sciences 21 (15), 5390, 2020 | 55 | 2020 |
| Increased level and fragmentation of plasma circulating cell-free DNA are diagnostic and prognostic markers for renal cell carcinoma Y Yamamoto, M Uemura, K Nakano, Y Hayashi, C Wang, Y Ishizuya, ... Oncotarget 9 (29), 20467, 2018 | 52 | 2018 |
| SERPINE2 is a possible candidate promotor for lymph node metastasis in testicular cancer A Nagahara, M Nakayama, D Oka, M Tsuchiya, A Kawashima, M Mukai, ... Biochemical and biophysical research communications 391 (4), 1641-1646, 2010 | 51 | 2010 |
| Peripheral T cell cytotoxicity predicts T cell function in the tumor microenvironment K Iwahori, Y Shintani, S Funaki, Y Yamamoto, M Matsumoto, T Yoshida, ... Scientific reports 9 (1), 2636, 2019 | 49 | 2019 |
| Increased Tim-3+ T cells in PBMCs during nivolumab therapy correlate with responses and prognosis of advanced esophageal squamous cell carcinoma patients R Kato, M Yamasaki, S Urakawa, K Nishida, T Makino, ... Cancer Immunology, Immunotherapy 67, 1673-1683, 2018 | 48 | 2018 |
| Pulmonary metastasectomy in patients with renal cell carcinoma: a single-institution experience A Kawashima, M Nakayama, D Oka, M Sato, K Hatano, M Mukai, ... International journal of clinical oncology 16, 660-665, 2011 | 43 | 2011 |
| Drug‐sensitivity of the Shigella strains isolated in 1955 O Kitamoto J. Japan. Assoc. Infect. Dis. 30, 403, 1956 | 43 | 1956 |
